Ashland Inc. (ASH)
NYSE: ASH · Real-Time Price · USD
51.88
-0.30 (-0.57%)
May 14, 2025, 1:51 PM - Market open
Revenue by Product
Fiscal year is October - September.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | NaN - NaN |
| Life Sciences | 693.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Life Sciences Growth | -17.89% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Personal Care | 617.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Personal Care Growth | 4.58% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Specialty Additives | 543.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Specialty Additives Growth | -5.57% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Intermediates | 142.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Intermediates Growth | -7.19% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Eliminations from | -45.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Eliminations from Growth | -10.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is October - September.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | NaN - NaN |
| Life Sciences Operating Income | 128.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Life Sciences Operating Income Growth | -20.99% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Personal Care Operating Income | 84.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Personal Care Operating Income Growth | 52.73% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Specialty Additives Operating Income | 21.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Specialty Additives Operating Income Growth | -136.84% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Intermediates Operating Income | 15.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Intermediates Operating Income Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Unallocated and Other Operating Income | -405.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Unallocated and Other Operating Income Growth | 202.24% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBITDA by Product
Fiscal year is October - September.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | NaN - NaN |
| Life Sciences EBITDA | 199.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Life Sciences EBITDA Growth | -13.10% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Personal Care EBITDA | 158.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Personal Care EBITDA Growth | 14.49% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Specialty Additives EBITDA | 94.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Specialty Additives EBITDA Growth | 42.42% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Intermediates EBITDA | 28.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Intermediates EBITDA Growth | -31.71% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Unallocated and Other EBITDA | -405.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Unallocated and Other EBITDA Growth | 202.24% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2019 |
|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | 2013 - 2019 |
| United States |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is October - September.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | NaN - NaN |
| Change in Sales Due to Volume | -7.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Change in Sales Due to Volume Growth | -820.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Change in Sales Due to Product Pricing/Mix | -64.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Change in Sales Due to Product Pricing/Mix Growth | -58.06% |
Log In |
Log In |
Log In |
Log In | Upgrade
|